Neuren Pharmaceuticals Limited's total assets for Q2 2024 were AU$228.15M, a decrease of -7.99% from the previous quarter. AU:NEU total liabilities were AU$9.00M for the fiscal quarter, a -78.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.